CIK 0001235912
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
CVRx, Inc.
Sign in to watch- Ticker
- CVRX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 763-416-2850
- Business address
- 9201 WEST BROADWAY AVENUE, SUITE 650, MINNEAPOLIS, MN, 55445
- Former names
- CVRX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-22 | BRINTNALL JOHN CHIEF STRATEGY OFFICER AND SEC | Option exercise | +1,590 | $0.24 | $377 | 12,040 |
| 2022-04-22 | BRINTNALL JOHN CHIEF STRATEGY OFFICER AND SEC | Option exercise | +2,584 | $0.24 | $612 | 14,624 |
| 2022-04-22 | BRINTNALL JOHN CHIEF STRATEGY OFFICER AND SEC | Option exercise | +2,221 | $0.24 | $526 | 16,845 |
| 2022-04-22 | BRINTNALL JOHN CHIEF STRATEGY OFFICER AND SEC | Option exercise | +3,792 | $0.24 | $899 | 20,637 |
| 2022-04-22 | BRINTNALL JOHN CHIEF STRATEGY OFFICER AND SEC | Option exercise | +1,264 | $0.24 | $300 | 21,901 |
| 2022-04-22 | BRINTNALL JOHN CHIEF STRATEGY OFFICER AND SEC | Option exercise · Stock Option (right to buy) | −1,590 | 685 | ||
| 2022-04-22 | BRINTNALL JOHN CHIEF STRATEGY OFFICER AND SEC | Option exercise · Stock Option (right to buy) | −2,584 | 702 | ||
| 2022-04-22 | BRINTNALL JOHN CHIEF STRATEGY OFFICER AND SEC | Option exercise · Stock Option (right to buy) | −2,221 | 0 | ||
| 2022-04-22 | BRINTNALL JOHN CHIEF STRATEGY OFFICER AND SEC | Option exercise · Stock Option (right to buy) | −3,792 | 0 | ||
| 2022-04-22 | BRINTNALL JOHN CHIEF STRATEGY OFFICER AND SEC | Option exercise · Stock Option (right to buy) | −1,264 | 0 | ||
| 2021-12-30 | BRINTNALL JOHN Chief Strategy Officer and Sec | Option exercise | +2,550 | $0.24 | $604 | 10,450 |
| 2021-12-30 | BRINTNALL JOHN Chief Strategy Officer and Sec | Option exercise · Stock Option (right to buy) | −2,550 | 2,221 | ||
| 2021-07-02 | BRINTNALL JOHN Chief Strategy Officer and Sec | Conversion | +2,242 | 2,242 | ||
| 2021-07-02 | BRINTNALL JOHN Chief Strategy Officer and Sec | Conversion | +5,658 | 7,900 | ||
| 2021-07-02 | BRINTNALL JOHN Chief Strategy Officer and Sec | Conversion · Series F-2 Preferred Stock | −88,653 | 0 | ||
| 2021-07-02 | BRINTNALL JOHN Chief Strategy Officer and Sec | Conversion · Series G-2 Preferred Stock | −89,518 | 0 | ||
| 2021-06-29 | BRINTNALL JOHN Chief Strategy Officer and Sec | Grant or award · Stock Option (right to buy) | +18,300 | 18,300 |
Page 1 of 1 · 17 trades